Skip to main content


Firm News

Mayer Brown represents Vidara Therapeutics International Ltd. in its acquisition by Horizon Pharma, Inc. for approximately $660 million

19 March 2014
Mayer Brown, a leading global law firm, is representing Vidara Therapeutics International Ltd., a specialty pharmaceutical company organized in Ireland, in connection with its acquisition by Horizon Pharma, Inc. through a reverse merger for stock and cash valued at approximately $660 million at the time of announcement. The surviving company, to be named Horizon Pharma plc, will be listed on NASDAQ.

The Mayer Brown team included: Corporate & Securities – partners Reb Wheeler and John Berkery and associates Ugo Ude, George Rudy, Mandee Lee and Tareah Ikharo (all New York); Tax Transactions & Consulting – partners Jason Bazar and Michael Marion and associate Lucas Giardelli (all New York); Employment & Benefits – partner Ryan Liebl and associate Katherine Dean (both Chicago); Intellectual Property – partner Rich Assmus (Chicago); and Antitrust & Competition – partner Scott Perlman (Washington DC).
The Build a Report feature requires the use of cookies to function properly. Cookies are small text files that are placed on your computer by websites that you visit. They are widely used in order to make websites work, or work more efficiently. If you do not accept cookies, this function will not work. For more information please see our Privacy Policy

You have no pages selected. Please select pages to email then resubmit.